Arcosa (US.ACA)
Capital Allocation Audit · Period: 2015 – 2026
Key Metrics
US.ACA · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 39.5% | ↓ |
| ROE | 1.4% | ↑ |
| Cash Conversion | 190.7% | ↑ |
| D/E Ratio | 0.57 | ↑ |
| Gross Margin | 21.1% | ↑ |
US.ACA (Arcosa) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY ---------------------------- FCF Conversion 39.5% ↓ ROE 1.4% ↑ Cash Conversion 190.7% ↑ D/E Ratio 0.57 ↑ Gross Margin 21.1% ↑
Key Metrics
US.ACA (Arcosa) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY----------------------------FCF Conversion 39.5% ↓ROE 1.4% ↑Cash Conversion 190.7% ↑D/E Ratio 0.57 ↑Gross Margin 21.1% ↑Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies